Medicine & Pharmaceuticals

Latest News Releases

*DISCLAIMER*: Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

Medicine & Pharmaceuticals News Releases via PRNewswireMore>>
Heartland Food Products Group Announces Milestone Breakthrough For Sucralose Production
Heartland Food Products Group Announces Milestone Breakthrough For Sucralose Production
Heartland Food Products Group, one of world's leading producers and marketers of zero calorie sweeteners and liquid water enhancers for consumer markets and its sister corporation Lexington Pharmaceuticals announce a...More >>
Heartland Food Products Group, one of world's leading producers and marketers of zero calorie sweeteners and liquid water enhancers for consumer markets and its sister corporation Lexington Pharmaceuticals announce a...More >>
Imagenetix: NIKKEN's Attempt To Invalidate Patent Fails
Imagenetix: NIKKEN's Attempt To Invalidate Patent Fails
Imagenetix, Inc. (OTC Bulletin Board: IAGXQ), announced today that the Board of Appeals for the United States Patent & Trade Office (USPTO) rejected NIKKEN's effort to invalidate Imagenetix's patent no....More >>
Imagenetix, Inc. (OTC Bulletin Board: IAGXQ), announced today that the Board of Appeals for the United States Patent & Trade Office (USPTO) rejected NIKKEN's effort to invalidate Imagenetix's patent no....More >>
Dementia Risk Greatest for Older Native Americans and African-Americans with Diabetes
Dementia Risk Greatest for Older Native Americans and African-Americans with Diabetes
In the first study to look at racial and ethnic differences in dementia risk among older adults with type 2 diabetes, researchers found that dementia was much higher among Native Americans and African-Americans and lowest...More >>
In the first study to look at racial and ethnic differences in dementia risk among older adults with type 2 diabetes, researchers found that dementia was much higher among Native Americans and African-Americans and lowest...More >>
New England Journal of Medicine releases study showing GSK's FluLaval Quadrivalent vaccine effective in preventing seasonal flu in children
New England Journal of Medicine releases study showing GSK's FluLaval Quadrivalent vaccine effective in preventing seasonal flu in children
GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that a peer-reviewed study issued online by the New England Journal of Medicine has reported that GSK's FluLaval® Quadrivalent reduced flu cases among children ages...More >>
GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that a peer-reviewed study issued online by the New England Journal of Medicine has reported that GSK's FluLaval® Quadrivalent reduced flu cases among children ages...More >>
Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock
Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock
Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a cash dividend of $3.00 per share on its...More >>
Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a cash dividend of $3.00 per share on its...More >>
Mary Ann Malack-Ragona Selected For "Health Care Heroes"
Mary Ann Malack-Ragona Selected For "Health Care Heroes"
Announcing a special recognition appearing in the November, 2013 issue of Long Island Business News published by Dolan Media Company. Mary Ann Malack-Ragona was selected for the following honor: "Health Care Heroes"More >>
Announcing a special recognition appearing in the November, 2013 issue of Long Island Business News published by Dolan Media Company. Mary Ann Malack-Ragona was selected for the following honor: "Health Care Heroes"More >>
Dr. James Geuder, Vascular Surgery, is named a Top Doctor: New York Metro Area
Dr. James Geuder, Vascular Surgery, is named a Top Doctor: New York Metro Area
Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has published the 16th edition of Top Doctors: New York Metro Area and has selected James Geuder, MD for this exclusive honor.More >>
Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has published the 16th edition of Top Doctors: New York Metro Area and has selected James Geuder, MD for this exclusive honor.More >>
FDA starts process to cut back antibiotic overuse in livestock
FDA starts process to cut back antibiotic overuse in livestock
The U.S. Food and Drug Administration (FDA) today is implementing plans to help phase out the use of antibiotics, medically important to fighting disease in humans, for enhancing growth or improving feed efficiency in...More >>
The U.S. Food and Drug Administration (FDA) today is implementing plans to help phase out the use of antibiotics, medically important to fighting disease in humans, for enhancing growth or improving feed efficiency in...More >>
Bioniche Life Sciences Inc. Delisting Approved by the ASX
Bioniche Life Sciences Inc. Delisting Approved by the ASX
BELLEVILLE, ON, Dec. 11, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC, ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announces that the Australian Securities Exchange...More >>
BELLEVILLE, ON, Dec. 11, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC, ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announces that the Australian Securities Exchange...More >>
Transcept Pharmaceuticals Announces that ISS Proxy Advisory Services Recommends "AGAINST" All Proposals Subject to a Vote at the December 19, 2013 Special Meeting of Stockholders
Transcept Pharmaceuticals Announces that ISS Proxy Advisory Services Recommends "AGAINST" All Proposals Subject to a Vote at the December 19, 2013 Special Meeting of Stockholders
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that ISS Proxy Advisory Services ("ISS"), a leading independent proxy voting and corporate governance advisory firm, has recommended that stockholders vote...More >>
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that ISS Proxy Advisory Services ("ISS"), a leading independent proxy voting and corporate governance advisory firm, has recommended that stockholders vote...More >>
Dr. Darlene McCord, Founder of McCord Research, Inc., Submits New Patent Application
Dr. Darlene McCord, Founder of McCord Research, Inc., Submits New Patent Application
McCord Research, Inc., founded by the renown biochemist, Darlene McCord, Ph.D., FAPWCA, has submitted a new patent application entitled "Hydroxytyrosol and Oleuropein Compositions For Induction of DNA Damage, Cell Death...More >>
McCord Research, Inc., founded by the renown biochemist, Darlene McCord, Ph.D., FAPWCA, has submitted a new patent application entitled "Hydroxytyrosol and Oleuropein Compositions For Induction of DNA Damage, Cell Death...More >>
Aratana Therapeutics to Participate in Upcoming Investor Events
Aratana Therapeutics to Participate in Upcoming Investor Events
Aratana Therapeutics (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it will participate in three upcoming...More >>
Aratana Therapeutics (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it will participate in three upcoming...More >>
Bosma Enterprises and Novia CareClinics partner to open The Woodland Center
Bosma Enterprises and Novia CareClinics partner to open The Woodland Center
As a proactive step toward enhancing their employees' health and wellness, Bosma Enterprises has launched an onsite health and wellness center in collaboration with Novia CareClinics (merging with QuadMed in 2014), and...More >>
As a proactive step toward enhancing their employees' health and wellness, Bosma Enterprises has launched an onsite health and wellness center in collaboration with Novia CareClinics (merging with QuadMed in 2014), and...More >>
BiOptix Continues Support of Antibody Engineering & Therapeutics Research
BiOptix Continues Support of Antibody Engineering & Therapeutics Research
BiOptix continues support of the global antibody engineering and therapeutics research community through participation in IBC's 24th Annual Antibody Engineering & Therapeutics Conference and annual meeting of The...More >>
BiOptix continues support of the global antibody engineering and therapeutics research community through participation in IBC's 24th Annual Antibody Engineering & Therapeutics Conference and annual meeting of The...More >>
MemorialCare Health System's Physician Organizations Achieve Top Honors from Integrated Healthcare Association and Other Statewide Groups
MemorialCare Health System's Physician Organizations Achieve Top Honors from Integrated Healthcare Association and Other Statewide Groups
MemorialCare Health System's two physician organizations that are part of its MemorialCare Medical Foundation-MemorialCare Medical Group and Greater Newport Physicians-have been named among the state's best medical...More >>
MemorialCare Health System's two physician organizations that are part of its MemorialCare Medical Foundation-MemorialCare Medical Group and Greater Newport Physicians-have been named among the state's best medical...More >>
Education Series Announced for InformEx 2014, Featuring Emerging Issues in Fine & Specialty Chemical Industry
Education Series Announced for InformEx 2014, Featuring Emerging Issues in Fine & Specialty Chemical Industry
InformEx, North America's leading business partnering event for buyers and sellers of high-value chemistry, has announced its lineup of education sessions for its 2014 conference and expo, to be held in Miami Beach,...More >>
InformEx, North America's leading business partnering event for buyers and sellers of high-value chemistry, has announced its lineup of education sessions for its 2014 conference and expo, to be held in Miami Beach,...More >>
Next Generation Stent Technologies (Technical Insights)
Next Generation Stent Technologies (Technical Insights)
Reportlinker.com announces that a new market research report is available in its catalogue: Next Generation Stent Technologies (Technical Insights) ...More >>
Reportlinker.com announces that a new market research report is available in its catalogue: Next Generation Stent Technologies (Technical Insights) ...More >>
Susan Duffy Joins McCann RCW As President
Susan Duffy Joins McCann RCW As President
As part of McCann Health's expansion of its professional communications capabilities in North America, Susan Duffy is joining the New York-based McCann Regan Campbell Ward as president. In this role, she will take over...More >>
As part of McCann Health's expansion of its professional communications capabilities in North America, Susan Duffy is joining the New York-based McCann Regan Campbell Ward as president. In this role, she will take over...More >>
Triangle Research Labs Announces Significant Expansion After Record-Setting 2013; Makes Company The World's Fastest-Growing Hepatocyte Provider
Triangle Research Labs Announces Significant Expansion After Record-Setting 2013; Makes Company The World's Fastest-Growing Hepatocyte Provider
Triangle Research Labs (TRL) announced today that it is aggressively expanding its business development operation to meet the increasing demands of a record-breaking 2013 that saw the company quadruple its business.More >>
Triangle Research Labs (TRL) announced today that it is aggressively expanding its business development operation to meet the increasing demands of a record-breaking 2013 that saw the company quadruple its business.More >>
Preventing Stark and Kickback Violations, Cyber Threats to Protected Health Information among interactive Advanced Discussion Group sessions at the 2014 Compliance Institute
Preventing Stark and Kickback Violations, Cyber Threats to Protected Health Information among interactive Advanced Discussion Group sessions at the 2014 Compliance Institute
Whether it is Preventing Stark and Kickback Violations, Handling Multiple External Audits and Compliance Reviews, or the Evolving Cyber Threats to Protected Health Information, health care compliance professionals looking...More >>
Whether it is Preventing Stark and Kickback Violations, Handling Multiple External Audits and Compliance Reviews, or the Evolving Cyber Threats to Protected Health Information, health care compliance professionals looking...More >>
3 Catalysts to Catapult Global Coronary Stent Market to $13 Billion, Says ABMRG
3 Catalysts to Catapult Global Coronary Stent Market to $13 Billion, Says ABMRG
http://www.abmrg.com/3-Catalysts-to-Catapult-Global-Coronary-Stent-Market-to-13-Billion.html According to ABMRG, a global authority on medtech market intelligence, the global coronary stent market is expected to be over...More >>
http://www.abmrg.com/3-Catalysts-to-Catapult-Global-Coronary-Stent-Market-to-13-Billion.html According to ABMRG, a global authority on medtech market intelligence, the global coronary stent market is expected to be over...More >>
Global Sterilization Market Report 2013-2017
Global Sterilization Market Report 2013-2017
Research and Markets (http://www.researchandmarkets.com/research/6h35cl/sterilization) has announced the addition of the "Global Sterilization Market Report 2013-2017" report to their offering.More >>
Research and Markets (http://www.researchandmarkets.com/research/6h35cl/sterilization) has announced the addition of the "Global Sterilization Market Report 2013-2017" report to their offering.More >>
Crime and Punishment: UMD Researchers Explain 'Third Party' Evolution
Crime and Punishment: UMD Researchers Explain 'Third Party' Evolution
You're shopping for holiday gifts in a department store when you spot someone pocketing a nice pair of leather gloves. What do you do?More >>
You're shopping for holiday gifts in a department store when you spot someone pocketing a nice pair of leather gloves. What do you do?More >>
Concerns Regarding Overstenting Will Limit the US Market for Interventional Cardiology Devices Through 2022
Concerns Regarding Overstenting Will Limit the US Market for Interventional Cardiology Devices Through 2022
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States market for interventional cardiology (IC) devices will be hindered by ongoing concerns over...More >>
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States market for interventional cardiology (IC) devices will be hindered by ongoing concerns over...More >>
Cardio3 BioSciences C-Cath® Article Published in Circulation Cardiovascular Interventions
Cardio3 BioSciences C-Cath® Article Published in Circulation Cardiovascular Interventions
Study Demonstrates Enhanced Endomyocardial Therapeutics Retention through an Optimized Delivery System Cardio3 BioSciences (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of...More >>
Study Demonstrates Enhanced Endomyocardial Therapeutics Retention through an Optimized Delivery System Cardio3 BioSciences (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of...More >>
SPIRITT Research Becomes Latest CRO To Join MedNet Solutions' iMedNet Partner Program
SPIRITT Research Becomes Latest CRO To Join MedNet Solutions' iMedNet Partner Program
MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that SPIRITT Research, a boutique research services organization with a passion for...More >>
MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that SPIRITT Research, a boutique research services organization with a passion for...More >>
XYMOGEN Launches Adrenal Manager Supplement To Help Control Bodily Response To Stress
XYMOGEN Launches Adrenal Manager Supplement To Help Control Bodily Response To Stress
Orlando-based health-sciences company XYMOGEN recently announced the launch of the Adrenal Manager, the newest formula in their long line of exclusive, professional dietary supplements.More >>
Orlando-based health-sciences company XYMOGEN recently announced the launch of the Adrenal Manager, the newest formula in their long line of exclusive, professional dietary supplements.More >>
Cardica Announces Commercial Availability of White Cartridge for MicroCutter XCHANGE™ 30 Cutting/Stapling Device
Cardica Announces Commercial Availability of White Cartridge for MicroCutter XCHANGE™ 30 Cutting/Stapling Device
Cardica, Inc. (Nasdaq: CRDC) today announced the commercial availability of the white cartridge for its MicroCutter XCHANGE™ 30 in Europe. Following extensive product testing to confirm reliability and functionality,...More >>
Cardica, Inc. (Nasdaq: CRDC) today announced the commercial availability of the white cartridge for its MicroCutter XCHANGE™ 30 in Europe. Following extensive product testing to confirm reliability and functionality,...More >>
UrgentRx® Announces New Retail Partnership with Allegiant® Air
UrgentRx® Announces New Retail Partnership with Allegiant® Air
UrgentRx, developer of fast-acting over-the-counter flavored powder medication, announced today a new partnership with Allegiant Air, one of the country's largest low cost carriers. Allegiant will be the first airline...More >>
UrgentRx, developer of fast-acting over-the-counter flavored powder medication, announced today a new partnership with Allegiant Air, one of the country's largest low cost carriers. Allegiant will be the first airline...More >>
OrthoAccel® Technologies, Inc. Launches Investigator Initiated Research Program with Announcement of Four Inaugural Grant Recipients
OrthoAccel® Technologies, Inc. Launches Investigator Initiated Research Program with Announcement of Four Inaugural Grant Recipients
OrthoAccel® Technologies, Inc. launches its Investigator Initiated Research Program by awarding initial grants to four academic research institutions. With patient demand steadily trending towards faster orthodontic...More >>
OrthoAccel® Technologies, Inc. launches its Investigator Initiated Research Program by awarding initial grants to four academic research institutions. With patient demand steadily trending towards faster orthodontic...More >>
Global microRNA (miRNA) Market Outlook to 2018
Global microRNA (miRNA) Market Outlook to 2018
The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over...More >>
The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over...More >>
Endo Health Solutions Announces Proposed Private Offering of Senior Notes
Endo Health Solutions Announces Proposed Private Offering of Senior Notes
Endo Health Solutions (Nasdaq: ENDP) ("Endo") today announced that Endo Finance Co., its wholly-owned subsidiary ("Endo Finance"), intends to offer, subject to market and customary conditions, $375 million aggregate...More >>
Endo Health Solutions (Nasdaq: ENDP) ("Endo") today announced that Endo Finance Co., its wholly-owned subsidiary ("Endo Finance"), intends to offer, subject to market and customary conditions, $375 million aggregate...More >>
CureDiva and Breastcancer.org Join Forces to Offer Women a One-Stop Shop and Community for All Breast Cancer Needs
CureDiva and Breastcancer.org Join Forces to Offer Women a One-Stop Shop and Community for All Breast Cancer Needs
CureDiva and Breastcancer.org are pleased to announce their official partnership. This collaboration offers women facing breast cancer a single destination where they can find support, and meet their educational and...More >>
CureDiva and Breastcancer.org are pleased to announce their official partnership. This collaboration offers women facing breast cancer a single destination where they can find support, and meet their educational and...More >>
The Acute Coronary Syndrome 12-Month Posthospital Market Will Double by 2022, Driven by the Uptake of Novel Lipid Modifying Agents
The Acute Coronary Syndrome 12-Month Posthospital Market Will Double by 2022, Driven by the Uptake of Novel Lipid Modifying Agents
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of numerous add-on therapies in the acute coronary syndrome (ACS) 12-month...More >>
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of numerous add-on therapies in the acute coronary syndrome (ACS) 12-month...More >>
Innovative Program Doubles Patient Engagement, Cuts Heart Failure Readmission Rate in Half
Innovative Program Doubles Patient Engagement, Cuts Heart Failure Readmission Rate in Half
A San Diego medical group's disease management program increased patient engagement rates from 28% to 67%, leading to a decline in both hospitalizations and 30-day readmissions for program participants. In recognition...More >>
A San Diego medical group's disease management program increased patient engagement rates from 28% to 67%, leading to a decline in both hospitalizations and 30-day readmissions for program participants. In recognition...More >>
Conn's, Caterpillar, Bristol-Myers Squibb, Novartis and AstraZeneca highlighted as Zacks Bull and Bear of the Day
Conn's, Caterpillar, Bristol-Myers Squibb, Novartis and AstraZeneca highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research highlights Conn's (Nasdaq:CONN-Free Report) as the Bull of the Day and Caterpillar (NYSE:CAT-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on the...More >>
Zacks Equity Research highlights Conn's (Nasdaq:CONN-Free Report) as the Bull of the Day and Caterpillar (NYSE:CAT-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on the...More >>
Cold-EEZE® Cold Remedy Supports the City Harvest Daily News Readers Care to Feed the Hungry Canned Food Drive (DNRC) for the Second Consecutive Year
Cold-EEZE® Cold Remedy Supports the City Harvest Daily News Readers Care to Feed the Hungry Canned Food Drive (DNRC) for the Second Consecutive Year
ProPhase Labs, Inc. (NASDAQ: PRPH), makers of Cold-EEZE® Cold Remedy and a leader in over-the-counter (OTC) natural cold remedies, has announced that for the second consecutive year it will support The Daily News Readers...More >>
ProPhase Labs, Inc. (NASDAQ: PRPH), makers of Cold-EEZE® Cold Remedy and a leader in over-the-counter (OTC) natural cold remedies, has announced that for the second consecutive year it will support The Daily News Readers...More >>
Apollo Medical Holdings and Boehringer Ingelheim to Collaborate On Care of ApolloMed Accountable Care Organization (ACO) Patients with COPD
Apollo Medical Holdings and Boehringer Ingelheim to Collaborate On Care of ApolloMed Accountable Care Organization (ACO) Patients with COPD
Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), an integrated physician-driven healthcare delivery company, and Boehringer Ingelheim Pharmaceuticals, Inc., a research-based, global pharmaceutical company, today...More >>
Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), an integrated physician-driven healthcare delivery company, and Boehringer Ingelheim Pharmaceuticals, Inc., a research-based, global pharmaceutical company, today...More >>
Reversal of Fate: Hisense Medical Equipment Pivotal in Saving of a Two-year-old Child with Liver Cancer
Reversal of Fate: Hisense Medical Equipment Pivotal in Saving of a Two-year-old Child with Liver Cancer
A 2-year-old child with a large liver tumor, a case that had been deemed as hopeless by several large hospitals, underwent surgery to successfully remove the tumor in Qingdao on Dec 3. With the help of medical equipment...More >>
A 2-year-old child with a large liver tumor, a case that had been deemed as hopeless by several large hospitals, underwent surgery to successfully remove the tumor in Qingdao on Dec 3. With the help of medical equipment...More >>
Merriman Capital to Host Pressure BioSciences, Inc. Investor Call at 4:30 p.m. EST on Thursday, December 12, 2013
Merriman Capital to Host Pressure BioSciences, Inc. Investor Call at 4:30 p.m. EST on Thursday, December 12, 2013
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), will host an investor call for...More >>
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), will host an investor call for...More >>
First Aid Shot Therapy® Revolutionizes Pain Relief with New Single-Dose OTC Liquid Shot
First Aid Shot Therapy® Revolutionizes Pain Relief with New Single-Dose OTC Liquid Shot
When the former Head of Gastroenterology at Stanford University and now current Professor of Medicine at John Hopkins School of Medicine teamed up with a former Coca-Cola executive to design a new over-the-counter (OTC)...More >>
When the former Head of Gastroenterology at Stanford University and now current Professor of Medicine at John Hopkins School of Medicine teamed up with a former Coca-Cola executive to design a new over-the-counter (OTC)...More >>
Liquidity Services Delivers Surplus Asset Solutions in Support of Hoffmann-La Roche's Consolidation Initiative
Liquidity Services Delivers Surplus Asset Solutions in Support of Hoffmann-La Roche's Consolidation Initiative
As part of its ongoing commitment to providing asset management and auction services for Hoffmann-La Roche Inc. (Roche), Liquidity Services, Inc. (NASDAQ: LQDT) will be conducting a series of online auctions for surplus...More >>
As part of its ongoing commitment to providing asset management and auction services for Hoffmann-La Roche Inc. (Roche), Liquidity Services, Inc. (NASDAQ: LQDT) will be conducting a series of online auctions for surplus...More >>
Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products
Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products
Sutro Biopharma today announced that the company has secured $26 million in a Series D financing. The additional financing will fund the expansion of Sutro's proprietary immuno-oncology product pipeline. Sutro is...More >>
Sutro Biopharma today announced that the company has secured $26 million in a Series D financing. The additional financing will fund the expansion of Sutro's proprietary immuno-oncology product pipeline. Sutro is...More >>
Medbox Executes Consulting Agreement with Licensed Medical Cannabis Laboratory and Cultivation Center in Canada
Medbox Executes Consulting Agreement with Licensed Medical Cannabis Laboratory and Cultivation Center in Canada
Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced execution of a consulting agreement...More >>
Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced execution of a consulting agreement...More >>
QRxPharma Announces 25 May 2014 as New PDUFA Date for MOXDUO® NDA
QRxPharma Announces 25 May 2014 as New PDUFA Date for MOXDUO® NDA
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) has established 25 May 2014 as the new Prescription Drug User Fee Act (PDUFA) date for action on the...More >>
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) has established 25 May 2014 as the new Prescription Drug User Fee Act (PDUFA) date for action on the...More >>
CommonWell Health Alliance to Launch Initial Interoperability Service Offerings in Illinois, North Carolina and South Carolina
CommonWell Health Alliance to Launch Initial Interoperability Service Offerings in Illinois, North Carolina and South Carolina
CommonWell Health Alliance (the "Alliance") – the health information technology (HIT) vendor-led interoperability effort – announced today that Chicago, Illinois; Elkin and Henderson, North Carolina; and Columbia, South...More >>
CommonWell Health Alliance (the "Alliance") – the health information technology (HIT) vendor-led interoperability effort – announced today that Chicago, Illinois; Elkin and Henderson, North Carolina; and Columbia, South...More >>
The National Parkinson Foundation Announces Grant Funding Opportunities for Research in Parkinson's Disease
The National Parkinson Foundation Announces Grant Funding Opportunities for Research in Parkinson's Disease
The National Parkinson Foundation (NPF) announced the launch of a new grant cycle today with the goal of developing the next generation of leaders in Parkinson's disease (PD) by supporting their research in areas voted...More >>
The National Parkinson Foundation (NPF) announced the launch of a new grant cycle today with the goal of developing the next generation of leaders in Parkinson's disease (PD) by supporting their research in areas voted...More >>
Prime Therapeutics wins five 2013 MarCom Awards
Prime Therapeutics wins five 2013 MarCom Awards
For the outstanding quality and creativity of its video production and business-to-business communications, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager, received five MarCom Awards. Prime's...More >>
For the outstanding quality and creativity of its video production and business-to-business communications, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager, received five MarCom Awards. Prime's...More >>
Bayer HealthCare Announces Collaboration with the University of Texas MD Anderson Cancer Center
Bayer HealthCare Announces Collaboration with the University of Texas MD Anderson Cancer Center
Bayer HealthCare announced today that the company has signed a master agreement for the performance of clinical trials with the Houston-based University of Texas MD Anderson Cancer Center.More >>
Bayer HealthCare announced today that the company has signed a master agreement for the performance of clinical trials with the Houston-based University of Texas MD Anderson Cancer Center.More >>
Celladon Corporation Announces Receipt of EMA Scientific Advice for MYDICAR® and Initiation of AGENT-HF Trial
Celladon Corporation Announces Receipt of EMA Scientific Advice for MYDICAR® and Initiation of AGENT-HF Trial
Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that the Company has received requested...More >>
Celladon Corporation, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that the Company has received requested...More >>
Jim Barone Named Health Care Service Corporation's Volunteer Of The Year
Jim Barone Named Health Care Service Corporation's Volunteer Of The Year
Jim Barone, director of Strategic Sourcing at Health Care Service Corporation was recognized as the 2013 Blue Corps Volunteer of the Year. For more than ten years, Barone has demonstrated commendable leadership and...More >>
Jim Barone, director of Strategic Sourcing at Health Care Service Corporation was recognized as the 2013 Blue Corps Volunteer of the Year. For more than ten years, Barone has demonstrated commendable leadership and...More >>
Antimicrobial Coatings Market Worth $2.9 Billion by 2018
Antimicrobial Coatings Market Worth $2.9 Billion by 2018
The "Antimicrobial Coatings Market by Type (Silver, Copper, and others such as Zinc Oxide, Titanium Dioxide, and Zinc Omadine), Application (Indoor air/HVAC, Medical, Mold remediation, Building & Construction, Food...More >>
The "Antimicrobial Coatings Market by Type (Silver, Copper, and others such as Zinc Oxide, Titanium Dioxide, and Zinc Omadine), Application (Indoor air/HVAC, Medical, Mold remediation, Building & Construction, Food...More >>
The Female Health Company Names Karen King President and Chief Executive Officer
The Female Health Company Names Karen King President and Chief Executive Officer
Today The Female Health Company (NASDAQ-CM: FHCO), announced that Karen King will become President and CEO effective January 20, 2014. O.B. Parrish, a Company founder and current Chairman and CEO will continue as Chairman...More >>
Today The Female Health Company (NASDAQ-CM: FHCO), announced that Karen King will become President and CEO effective January 20, 2014. O.B. Parrish, a Company founder and current Chairman and CEO will continue as Chairman...More >>
COMS Interactive Expands Partnership with Maun-Lemke
COMS Interactive Expands Partnership with Maun-Lemke
COMS Interactive (commonly known as COMS or Clinical Outcomes Management Systems) has expanded the existing partnership with Maun-Lemke, LLC with an increased focus on revenue generation. The two companies are joining...More >>
COMS Interactive (commonly known as COMS or Clinical Outcomes Management Systems) has expanded the existing partnership with Maun-Lemke, LLC with an increased focus on revenue generation. The two companies are joining...More >>
GrowLife Names Former Microsoft, Yahoo! Exec, Marco Hegyi, as New President
GrowLife Names Former Microsoft, Yahoo! Exec, Marco Hegyi, as New President
GrowLife, Inc. (OTCBB: PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations,...More >>
GrowLife, Inc. (OTCBB: PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations,...More >>
Sprout Pharmaceuticals Appeals FDA Decision On New Drug Application For Flibanserin To Treat Hypoactive Sexual Desire Disorder In Premenopausal Women
Sprout Pharmaceuticals Appeals FDA Decision On New Drug Application For Flibanserin To Treat Hypoactive Sexual Desire Disorder In Premenopausal Women
Sprout Pharmaceuticals today announced that it has received and appealed the Food and Drug Administration's (FDA) Complete Response Letter (CRL) for flibanserin through the Formal Dispute Resolution process....More >>
Sprout Pharmaceuticals today announced that it has received and appealed the Food and Drug Administration's (FDA) Complete Response Letter (CRL) for flibanserin through the Formal Dispute Resolution process....More >>
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, has been invited to participate on an expert panel titled, Ovarian & Cervical Cancer – Evaluating the Role of...More >>
Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, has been invited to participate on an expert panel titled, Ovarian & Cervical Cancer – Evaluating the Role of...More >>
Actavis Announces Tentative Agreement Related to Asacol® HD Patent Challenge Litigation
Actavis Announces Tentative Agreement Related to Asacol® HD Patent Challenge Litigation
Actavis plc (NYSE: ACT), a leading specialty pharmaceutical company, today announced that it its subsidiary, Warner Chilcott Company, LLC, has entered into an agreement in principle with Zydus Pharmaceuticals USA Inc. and...More >>
Actavis plc (NYSE: ACT), a leading specialty pharmaceutical company, today announced that it its subsidiary, Warner Chilcott Company, LLC, has entered into an agreement in principle with Zydus Pharmaceuticals USA Inc. and...More >>
Veloxis Pharmaceuticals Announces Initiation of ASERTAA Study of ENVARSUS® in African-American Kidney Transplant Recipients
Veloxis Pharmaceuticals Announces Initiation of ASERTAA Study of ENVARSUS® in African-American Kidney Transplant Recipients
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced dosing of the first patient in ASERTAA (A Study of Extended Release Tacrolimus in African-Americans) Phase IIIb study of ENVARSUS® (formerly LCP Tacro™) in kidney...More >>
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced dosing of the first patient in ASERTAA (A Study of Extended Release Tacrolimus in African-Americans) Phase IIIb study of ENVARSUS® (formerly LCP Tacro™) in kidney...More >>
HealthWell Foundation® Launches New Peyronie's Fund
HealthWell Foundation® Launches New Peyronie's Fund
The HealthWell Foundation, an independent non-profit providing nationwide financial assistance to insured Americans with high out-of-pocket medication expenses, today announced the launch of a new fund to assist patients...More >>
The HealthWell Foundation, an independent non-profit providing nationwide financial assistance to insured Americans with high out-of-pocket medication expenses, today announced the launch of a new fund to assist patients...More >>
The Ovarian Cancer Drug Market is Set to More Than Double to $1.6 Billion by 2022
The Ovarian Cancer Drug Market is Set to More Than Double to $1.6 Billion by 2022
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Roche/Genentech/Chugai's Avastin will penetrate nearly all segments of the ovarian...More >>
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Roche/Genentech/Chugai's Avastin will penetrate nearly all segments of the ovarian...More >>
Use of Roche's Herceptin Among HER2+ Gastric Cancer Patients May Double in China Over the Next Three Years
Use of Roche's Herceptin Among HER2+ Gastric Cancer Patients May Double in China Over the Next Three Years
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that oncologists in China are embracing Roche's Herceptin as the targeted therapy for...More >>
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that oncologists in China are embracing Roche's Herceptin as the targeted therapy for...More >>
Orexigen Resubmits Contrave New Drug Application
Orexigen Resubmits Contrave New Drug Application
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Company has resubmitted the Contrave® New Drug Application to the United States (U.S.) Food and Drug Administration (FDA). Investigational drug Contrave...More >>
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Company has resubmitted the Contrave® New Drug Application to the United States (U.S.) Food and Drug Administration (FDA). Investigational drug Contrave...More >>
MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2013 Financial Results on Thursday, December 19, 2013
MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2013 Financial Results on Thursday, December 19, 2013
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today scheduled a conference call to discuss its financial results for the fourth quarter and fiscal year 2013, ended October 31, 2013. The...More >>
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today scheduled a conference call to discuss its financial results for the fourth quarter and fiscal year 2013, ended October 31, 2013. The...More >>
New Power Of Personalized Medicine For Baby Described At March Of Dimes Luncheon
New Power Of Personalized Medicine For Baby Described At March Of Dimes Luncheon
The ability to analyze a hospitalized newborn's genome within hours rather than weeks is helping doctors diagnose babies' illnesses and provide treatment that is individualized to an infant's specific genetic...More >>
The ability to analyze a hospitalized newborn's genome within hours rather than weeks is helping doctors diagnose babies' illnesses and provide treatment that is individualized to an infant's specific genetic...More >>
Study examines new class of anticoagulants for VTE prevention and treatment
Study examines new class of anticoagulants for VTE prevention and treatment
$1.7 million award supports University of Michigan collaboration with GlycoMimetics, Inc.More >>
$1.7 million award supports University of Michigan collaboration with GlycoMimetics, Inc.More >>
ULURU Inc. Announces the Expansion of the International Marketing Network
ULURU Inc. Announces the Expansion of the International Marketing Network
ULURU Inc. (OTCQB: ULUR), today announced the expansion of the Altrazeal® international marketing network. Agreements have been signed granting the exclusive marketing and distribution rights for Altrazeal® in Italy, Spain...More >>
ULURU Inc. (OTCQB: ULUR), today announced the expansion of the Altrazeal® international marketing network. Agreements have been signed granting the exclusive marketing and distribution rights for Altrazeal® in Italy, Spain...More >>
VIVA Health, Inc. Leads U.S. Health Insurers with Adoption of MedSnap ID
VIVA Health, Inc. Leads U.S. Health Insurers with Adoption of MedSnap ID
VIVA Health, a member of the UAB Health System, has adopted MedSnap ID, a mobile medication safety technology that will allow its care managers to identify the medications a patient is taking and determine potential...More >>
VIVA Health, a member of the UAB Health System, has adopted MedSnap ID, a mobile medication safety technology that will allow its care managers to identify the medications a patient is taking and determine potential...More >>
GSW Launches Multi-Channel Detailing Platform and Expands Closed-Loop Marketing Suite
GSW Launches Multi-Channel Detailing Platform and Expands Closed-Loop Marketing Suite
GSW, an inVentiv Health company and leading healthcare communications agency, today released iQ.mercury 3, a significant advance in pharmaceutical detailing that is optimized both for Apple and Windows tablets. iQ.mercury...More >>
GSW, an inVentiv Health company and leading healthcare communications agency, today released iQ.mercury 3, a significant advance in pharmaceutical detailing that is optimized both for Apple and Windows tablets. iQ.mercury...More >>
Ginseng (CAS 90045-38-8) Market Research Report 2012
Ginseng (CAS 90045-38-8) Market Research Report 2012
Research and Markets (http://www.researchandmarkets.com/research/fzc9cs/ginseng_cas) has announced the addition of the "Ginseng (CAS 90045-38-8) Market Research Report 2012" report to their offering.More >>
Research and Markets (http://www.researchandmarkets.com/research/fzc9cs/ginseng_cas) has announced the addition of the "Ginseng (CAS 90045-38-8) Market Research Report 2012" report to their offering.More >>
AcelRx Pharmaceuticals Adds New Board Member
AcelRx Pharmaceuticals Adds New Board Member
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced...More >>
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced...More >>
Global Biological Standards Institute Engages Life Science Community to Address Irreproducibility of Research Findings
Global Biological Standards Institute Engages Life Science Community to Address Irreproducibility of Research Findings
The Global Biological Standards Institute (GBSI) today presented findings from the first comprehensive report on the state of the field of life science research quality. GBSI commissioned the report to assess the quality...More >>
The Global Biological Standards Institute (GBSI) today presented findings from the first comprehensive report on the state of the field of life science research quality. GBSI commissioned the report to assess the quality...More >>
Otonomy Doses First Subjects in Phase 3 Clinical Trials of OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery
Otonomy Doses First Subjects in Phase 3 Clinical Trials of OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced dosing of the first patients in its two Phase 3 trials of...More >>
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced dosing of the first patients in its two Phase 3 trials of...More >>
Otonomy Enrolls First Patient in Pivotal Phase 2b Study of OTO-104 in Meniere's Disease
Otonomy Enrolls First Patient in Pivotal Phase 2b Study of OTO-104 in Meniere's Disease
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced enrollment of the first patient in its pivotal Phase 2b...More >>
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced enrollment of the first patient in its pivotal Phase 2b...More >>
FDA Selects Neurotechnology Industry Organization Director To Device Advisory Committee
FDA Selects Neurotechnology Industry Organization Director To Device Advisory Committee
The Food and Drug Administration's Center for Devices and Radiological Health has selected John Reppas, MD, PhD, and Director of Public Policy at the Neurotechnology Industry Organization, to serve as industry...More >>
The Food and Drug Administration's Center for Devices and Radiological Health has selected John Reppas, MD, PhD, and Director of Public Policy at the Neurotechnology Industry Organization, to serve as industry...More >>
Harrington Discovery Institute At University Hospitals Case Medical Center Announces Grant Funding To Physician-scientists At Major Academic Medical Centers Nationwide To Support New Drug Development
Harrington Discovery Institute At University Hospitals Case Medical Center Announces Grant Funding To Physician-scientists At Major Academic Medical Centers Nationwide To Support New Drug Development
The Harrington Discovery Institute at University Hospitals (UH) Case Medical Center has announced the 2014 recipients of Harrington Scholar-Innovator Awards. The awards will support drug discovery efforts of great promise...More >>
The Harrington Discovery Institute at University Hospitals (UH) Case Medical Center has announced the 2014 recipients of Harrington Scholar-Innovator Awards. The awards will support drug discovery efforts of great promise...More >>
First And Only Skincare To Use Plant And Human Adult Stem Cell Technology Launches
First And Only Skincare To Use Plant And Human Adult Stem Cell Technology Launches
DermaTech Research Laboratories announced the launch of Stemology®, the world's first and only skincare line to incorporate the superior features of both human adult stem cells and plant stem cells, along with a stem...More >>
DermaTech Research Laboratories announced the launch of Stemology®, the world's first and only skincare line to incorporate the superior features of both human adult stem cells and plant stem cells, along with a stem...More >>
AlzeCure Implements Vortex to Enhance Research Efforts in Alzheimer's Disease
AlzeCure Implements Vortex to Enhance Research Efforts in Alzheimer's Disease
Dotmatics' Vortex to be used to uncover new drug lead compounds for Alzheimer's disease Dotmatics, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology...More >>
Dotmatics' Vortex to be used to uncover new drug lead compounds for Alzheimer's disease Dotmatics, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology...More >>
IMD Companies, Inc. (ICBU) Gives Corporate Update and Becomes Current with all its Financial Filings
IMD Companies, Inc. (ICBU) Gives Corporate Update and Becomes Current with all its Financial Filings
TAMPA, FL, Dec. 11, 2013 /PRNewswire/ - IMD Companies, Inc. (OTC.PK: ICBU) Gives Corporate Update as a step in the continued execution of our repositioning strategy. The company has recently brought its reporting up to...More >>
TAMPA, FL, Dec. 11, 2013 /PRNewswire/ - IMD Companies, Inc. (OTC.PK: ICBU) Gives Corporate Update as a step in the continued execution of our repositioning strategy. The company has recently brought its reporting up to...More >>
Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer
Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that Douglas J. Beck C.P.A. joined the company as its Chief Financial Officer where he will...More >>
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that Douglas J. Beck C.P.A. joined the company as its Chief Financial Officer where he will...More >>
Can-Fite CEO Issues Letter to Shareholders
Can-Fite CEO Issues Letter to Shareholders
Can-Fite BioPharma (NYSE MKT: CANF), (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address anti-inflammatory and cancer diseases, today issued a Letter to Shareholders.More >>
Can-Fite BioPharma (NYSE MKT: CANF), (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address anti-inflammatory and cancer diseases, today issued a Letter to Shareholders.More >>
Savient Reaches Agreement To Sell Substantially All Assets To Crealta Pharmaceuticals
Savient Reaches Agreement To Sell Substantially All Assets To Crealta Pharmaceuticals
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) ("Savient") announced today that it has reached agreement on the terms of an acquisition agreement with Crealta Pharmaceuticals LLC ("Crealta") through which Crealta would...More >>
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) ("Savient") announced today that it has reached agreement on the terms of an acquisition agreement with Crealta Pharmaceuticals LLC ("Crealta") through which Crealta would...More >>
Henry Schein To Host 2013 Analyst And Investor Day
Henry Schein To Host 2013 Analyst And Investor Day
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced that the Company will host an analyst and...More >>
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced that the Company will host an analyst and...More >>
Hart-Scott-Rodino Waiting Period Expires for Shire's Acquisition of ViroPharma
Hart-Scott-Rodino Waiting Period Expires for Shire's Acquisition of ViroPharma
Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) relating to its previously announced tender offer by a wholly owned subsidiary of...More >>
Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) relating to its previously announced tender offer by a wholly owned subsidiary of...More >>
Questcor Announces Quarterly Cash Dividend and Provides Update on Share Repurchase Program
Questcor Announces Quarterly Cash Dividend and Provides Update on Share Repurchase Program
Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share ($1.20 per share on an annual basis). The dividend will be paid on or...More >>
Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share ($1.20 per share on an annual basis). The dividend will be paid on or...More >>
bioCorneum+ Has 10 Million+ Reasons for You to "Meet the Plastic Surgeons"
bioCorneum+ Has 10 Million+ Reasons for You to "Meet the Plastic Surgeons"
bioCorneum (www.biocorneum.com) COO Zubin Meshginpoosh and the enaltus team has developed a new Facebook series that will feature plastic surgeons discussing key information for patients to assist in making informed...More >>
bioCorneum (www.biocorneum.com) COO Zubin Meshginpoosh and the enaltus team has developed a new Facebook series that will feature plastic surgeons discussing key information for patients to assist in making informed...More >>
Surefire Medical Completes Enrollment in the COSY Clinical Trial to Improve Liver Cancer Embolization
Surefire Medical Completes Enrollment in the COSY Clinical Trial to Improve Liver Cancer Embolization
Surefire Medical, Inc. today announced that it has completed enrollment in the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial. This randomized prospective study investigates the feasibility and benefits...More >>
Surefire Medical, Inc. today announced that it has completed enrollment in the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial. This randomized prospective study investigates the feasibility and benefits...More >>
Elsevier First to Publish NADAC Price Type from CMS
Elsevier First to Publish NADAC Price Type from CMS
Elsevier's Gold Standard is the first drug database to include CMS's survey-based pricing, making it the most comprehensive source for drug price benchmarks Elsevier, a world-leading provider of scientific,...More >>
Elsevier's Gold Standard is the first drug database to include CMS's survey-based pricing, making it the most comprehensive source for drug price benchmarks Elsevier, a world-leading provider of scientific,...More >>
SynCardia Hits Record-Setting 150th Implant of the Total Artificial Heart in 2013
SynCardia Hits Record-Setting 150th Implant of the Total Artificial Heart in 2013
SynCardia Systems, Inc. continues to set records with the implantation of the year's 150th SynCardia temporary Total Artificial Heart on Nov. 26, 2013. With almost three weeks left in 2013, SynCardia projects beating...More >>
SynCardia Systems, Inc. continues to set records with the implantation of the year's 150th SynCardia temporary Total Artificial Heart on Nov. 26, 2013. With almost three weeks left in 2013, SynCardia projects beating...More >>
China Pharmaceutical Guidebook: (2013 Edition) Latest Chinese Regulations for Imported Drug Registration
China Pharmaceutical Guidebook: (2013 Edition) Latest Chinese Regulations for Imported Drug Registration
Bharat book Bureau presents China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug...More >>
Bharat book Bureau presents China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug...More >>
Industrial Electronics - Global Trends, Estimates and Forecasts, 2011-2018
Industrial Electronics - Global Trends, Estimates and Forecasts, 2011-2018
Bharat Book Bureau presents Industrial Electronics - Global Trends, Estimates and Forecasts, 2011-2018. This report Primarily supported by application sectors:- semiconductor capital equipment, test and measuring (T&M)...More >>
Bharat Book Bureau presents Industrial Electronics - Global Trends, Estimates and Forecasts, 2011-2018. This report Primarily supported by application sectors:- semiconductor capital equipment, test and measuring (T&M)...More >>
GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma
GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma
GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product...More >>
GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product...More >>
Back App: Proven to Reduce Back Pain - Another Triumph of Nordic Design
Back App: Proven to Reduce Back Pain - Another Triumph of Nordic Design
Back App, proven to improve back pain and prevent office workers from falling victim to Sitting Disease, is a chair that is very different from all others. To view the Multimedia News Release, please click: ...More >>
Back App, proven to improve back pain and prevent office workers from falling victim to Sitting Disease, is a chair that is very different from all others. To view the Multimedia News Release, please click: ...More >>
Pain Management Solutions for a Patient Suffering From Chronic Pain
Pain Management Solutions for a Patient Suffering From Chronic Pain
Pain management as an independent medical field has been significantly growing during the last few decades. Doctors and clinics specialize in the treatment of pain in general and chronic pain specifically. These...More >>
Pain management as an independent medical field has been significantly growing during the last few decades. Doctors and clinics specialize in the treatment of pain in general and chronic pain specifically. These...More >>
ANI Pharmaceuticals Presents At Oppenheimer 24th Annual Healthcare Conference
ANI Pharmaceuticals Presents At Oppenheimer 24th Annual Healthcare Conference
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presented at the Oppenheimer & Co. 24th Annual Healthcare Conference at the Crowne Plaza Hotel in New York City. On December 10, 2013 at 4:30pm, Arthur S. Przybyl, President...More >>
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presented at the Oppenheimer & Co. 24th Annual Healthcare Conference at the Crowne Plaza Hotel in New York City. On December 10, 2013 at 4:30pm, Arthur S. Przybyl, President...More >>
Norman B. Rice To Retire As President & CEO Of The Seattle Foundation
Norman B. Rice To Retire As President & CEO Of The Seattle Foundation
Norman B. Rice announced today his intention to retire as president & CEO of The Seattle Foundation, as he enters his 40th year in public and community service to the Puget Sound region and the nation. Rice will...More >>
Norman B. Rice announced today his intention to retire as president & CEO of The Seattle Foundation, as he enters his 40th year in public and community service to the Puget Sound region and the nation. Rice will...More >>
Johns Hopkins-AHRQ Collaboration to Reduce Hospital-Acquired Infections Selects UHC
Johns Hopkins-AHRQ Collaboration to Reduce Hospital-Acquired Infections Selects UHC
UHC announced its selection as a coordinating entity for a 3-year, $7.3 million contract from the Agency for Healthcare Research and Quality (AHRQ) that has been awarded to the Johns Hopkins Armstrong Institute for Patient...More >>
UHC announced its selection as a coordinating entity for a 3-year, $7.3 million contract from the Agency for Healthcare Research and Quality (AHRQ) that has been awarded to the Johns Hopkins Armstrong Institute for Patient...More >>
Dr. Bruno E. Gerber is recognized by Continental Who's Who among Medical Professionals as a result of his ongoing excellence in the field
Dr. Bruno E. Gerber is recognized by Continental Who's Who among Medical Professionals as a result of his ongoing excellence in the field
Dr. Gerber is a Consultant Orthopedic Surgeon with a special interest in biologic surgical treatments of musculoskeletal conditions of the lower limbs. He also is employed as medical advisor in research and development of...More >>
Dr. Gerber is a Consultant Orthopedic Surgeon with a special interest in biologic surgical treatments of musculoskeletal conditions of the lower limbs. He also is employed as medical advisor in research and development of...More >>
Echo Therapeutics Announces Strategic Partnership with Medical Technologies Innovation Asia (MTIA)
Echo Therapeutics Announces Strategic Partnership with Medical Technologies Innovation Asia (MTIA)
Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a...More >>
Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a...More >>
Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
Pharmacyclics, Inc. (NASDAQ: PCYC) today announced results of 40 clinical, non-clinical and pre-clinical presentations on ibrutinib (IMBRUVICA™) at the 55TH Annual meeting of the American Society of Hematology (ASH) held...More >>
Pharmacyclics, Inc. (NASDAQ: PCYC) today announced results of 40 clinical, non-clinical and pre-clinical presentations on ibrutinib (IMBRUVICA™) at the 55TH Annual meeting of the American Society of Hematology (ASH) held...More >>
Long-term Use of Common Heartburn and Ulcer Medications Linked to Vitamin B12 Deficiency
Long-term Use of Common Heartburn and Ulcer Medications Linked to Vitamin B12 Deficiency
Long-term use of commonly prescribed heartburn and ulcer medications is linked to a higher risk of vitamin B12 deficiency, according to a new study published online in the Journal of the American Medical Association.More >>
Long-term use of commonly prescribed heartburn and ulcer medications is linked to a higher risk of vitamin B12 deficiency, according to a new study published online in the Journal of the American Medical Association.More >>

PR Newswire IndexMore>>
Entertainment News Releases via PRNewswire
Entertainment
Entertainment News Releases via PRNewswire
Travel
Travel News Releases via PRNewswire
Political Campaigns
Political Campaigns News Releases via PRNewswire
Medicine & Pharmaceuticals
Medicine & Pharmaceuticals News Releases via PRNewswire
Film & Motion Picture News Releases via PRNewswire
Film & Motion Picture
Film & Motion Picture News Releases via PRNewswire
Economic News and Analysis
Economic News Releases via PRNewswire
Computer Software
Computer Software News Releases via PRNewswire
Computer Networks
Computer Networks News Releases via PRNewswire
Computer Hardware
Computer Hardware News Releases via PRNewswire
Biotech News Releases via PRNewswire
Biotechnology
Biotechnology News Releases via PRNewswire

Medicine & Pharmaceuticals - Wandtv.com, NewsCenter17, StormCenter17, Central Illinois News-

Medicine & Pharmaceuticals News Releases via PRNewswireMore>>